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Abstract. The feasibility of spatial frequency domain imaging (SFDI) for breast surgical margin assessment was
evaluated in tissue-simulating phantoms and in fully intact lumpectomy specimens at the time of surgery.
Phantom data was evaluated according to contrast-detail resolution, quantitative accuracy and model-data good-
ness of fit, where optical parameters were estimated by minimizing the residual sum of squares between the mea-
sured modulation amplitude and its solutions, modeled according to diffusion and scaled-Monte Carlo simulations.
In contrast-detail phantoms, a 1.25-mm-diameter surface inclusion was detectable for scattering contrast >28%; a
fraction of this scattering contrast (7%) was detectable for a 10 mm surface inclusion and at least 33% scattering
contrast was detected up to 1.5 mm below the phantom surface, a probing depth relevant to breast surgical margin
assessment. Recovered hemoglobin concentrations were insensitive to changes in scattering, except for overesti-
mation at visible wavelengths for total hemoglobin concentrations <15 μM. The scattering amplitude increased
linearly with scattering concentration, but the scattering slope depended on both the particle size and number
density. Goodness of fit was comparable for the diffusion and scaled-Monte Carlo models of transport in spatially
modulated, near-infrared reflectance acquired from 47 lumpectomy tissues, but recovered absorption parameters
varied more linearly with expected hemoglobin concentration in liquid phantoms for the scaled-Monte Carlo
forward model. SFDI could potentially reduce the high secondary excision rate associated with breast conserving
surgery; its clinical translation further requires reduced image reconstruction time and smart inking strategies. © The
Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or reproduction of this work in whole or in part
requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.18.3.036012]
Keywords: spatial frequency domain imaging; modulated imaging, near-infrared spectroscopy; tissue scattering; pathology discrimina-
tion; breast conserving surgery; margin assessment.
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1 Introduction
The feasibility of spatial frequency domain imaging (SFDI) for
breast surgical margin assessment was evaluated using tissue-
simulating phantoms to measure quantitative accuracy and
contrast-detail resolution, and fully intact surgical specimens
to assess the clinical application of this acquisition geometry
to surgical breast tissues. SFDI projects sinusoidal patterns of
near-infrared (NIR) light onto biological tissues to quantify
wide-field spectral absorption and scattering. This unique
planar imaging modality was pioneered by investigators at
the University of California at Irvine and commercialized by
Modulated Imaging Inc. for biological imaging at a spatial
resolution between coherent and diffuse optical imaging.1
The frequency dependence of the modulation amplitude pro-
vides a sensitive measurement to uniquely separate optical
effects using analytical models of light transport; where high
spatial frequencies are sensitive to short pathlength pheno-
menon, primarily scattering by local fluctuations in tissue
morphology, and continuous illumination is sensitive to both
absorption and scattering.1 No exogenous probes were neces-
sary for microscopic specificity, but high spatial frequencies
were probed (up to 0.33 mm−1) to improve sensitivity to scat-
tering by tissue ultra-structure. The spatial frequency of the
illumination pattern integrated optical parameterization with
volume averaging in depth and improved signal localization—
optical parameters were recovered at depths approximately 1 to
8 mm,2 a range appropriate for surgical margin assessment.
The scattering spectrum can be exquisitely sensitive to mor-
phological transformations perceived by pathologists when the
confounding effects of multiple light scattering are minimized;
this is typically achieved through local sampling of reflectance
and/or polarization techniques.3–5 Near-source sampling of
reflectance by fiber-mediated probes has demonstrated specific
correlation with paraffin histology, the diagnostic gold standard,
and improved tissue-type discrimination because of sensitivity
to the scattering phase function.6–9 Optical coherence tomogra-
phy10 and confocal sampling geometries11,12 have also been
applied for intra-operative diagnoses, but are limited in depth
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resolution by a multiple scattering background and in field of
view (FOV) size (the microscopic FOV is often too small to
wholly analyze lumpectomy tissues in a clinically useful time-
frame). Diffuse optical tomography can be useful to quantify
bulk transformations in tissue physiology over several centi-
meters,13–15 but the spatial resolution corresponds to the scatter-
ing coefficient of the tissue16 and this can be insufficient to
resolve local transformations by important scattering structures
(which mainly have dimensions comparable to the optical wave-
length).17 As an intermediate between coherent and diffuse opti-
cal techniques, the ability of SFDI to effectively combine wide-
field optical imaging with localized scattering contrast is tested.
Scattering contrast-detail and contrast-depth resolution were
explored in homogeneous polymer and gelatin phantoms with
embedded inclusions because recent results suggest spectro-
scopic scattering features exhibited less variance within pathol-
ogy subtypes and was ranked as most significant to tissue-type
discrimination by an iterative feature ranking algorithm in a pilot
clinical study. Quantitative accuracy of the diffusion approxima-
tion and scaled-Monte Carlo models of light transport were then
compared in tissue simulating phantoms with expected optical
properties and finally, goodness of fit was evaluated in reflec-
tance measures acquired from 47 lumpectomy tissues to evalu-
ate application of these models to surgical breast tissues. The
diffusion approximation is valid for highly scattering media
and for large source-to-detector separations, where high photon
scattering renders their transport deterministic. Transport is gov-
erned by the reduced scattering coefficient and the absorption
coefficient; consequently, information pertaining to the specific
phase function is lost18 and scattering can be convolved with
absorption effects if reflectance is not measured at multiple
source-to-detector separations, or equivalently, at multiple spa-
tial frequencies. Spatially resolved, analytical solutions to the
steady state diffusion approximation have been derived by
Farrell and Dognitz in the real and spatial-frequency domains,
respectively.19,20 These models have demonstrated utility when
tailored to specific sampling geometries21,22 and have been
improved by higher order approximations to the phase func-
tion.23 The diffusion approximation was compared to a forward
model based on scaled-Monte Carlo simulations of light trans-
port for sampling at high spatial frequency because direct Monte
Carlo simulations were computationally too expensive for an
iterative optimization.1 Numerical models were generated by
rescaling a single Monte Carlo simulation to extract a wide
range of optical properties from spatial-frequency dependent
measures, as first realized by Graaff et al.24 and Kienle et al.25
The feasibility of SFDI to distinguish malignant transforma-
tions immediately ex vivo in the surgical environment, prior to
routine pathological processing, was evaluated in four fully
intact, lumpectomy tissues in order to eventually reduce the
high rate of secondary excision associated with breast conserv-
ing therapy (BCT).26 BCT, which includes local tumor excision
followed by moderate dose-radiation therapy, was the treatment
of choice for nearly 75% of the approximately 300,000 new
breast cancer patients diagnosed in 2011.27 Its survival rates
are equivalent to those of mastectomy when surgical resection
margins are negative for residual cancer,28,29 but margins posi-
tive for residual cancer have been associated with an increased
risk of local recurrence30–32 and mortality.33 Margin assessment
is routinely performed post-operatively by paraffin histology
because frozen section analysis is limited by freezing artifacts
in adipose tissues.34,35 At Dartmouth-Hitchcock Medical Center
(DHMC), colored inks are superficially applied to the resected
tissue to define margins for post-operative assessment and sur-
gical margins are re-excised if invasive tumor is detected at the
margin or if ductal carcinoma in situ (DCIS) is detected less than
2 mm from the inked surface.36 Tissues excised during breast
conserving surgery (BCS) may include tumors up to 5 cm in
diameter, surrounded by a targeted layer of grossly normal tissue
that is nearly 1 cm thick. Ideally, SFDI might be used to assess
the full tumor specimen in a noncontact manner, while maintain-
ing sensitivity to malignant transformations in localized
volumes.
2 Methods
2.1 Spatial Frequency Domain Imaging System
A compact SFDI system, purchased from Modulating Imaging
Inc., was used to quantitatively image optical parameters at four
NIR wavelengths (658, 730, 850, and 970 nm) using spatially
varying light. In series, 30 spatial frequencies uniformly distrib-
uted from 0 mm−1 up to 0.33 mm−1 were projected per wave-
length onto each sample using high power light-emitting diodes
(LEDs), a projection system and a digital micro-mirror device.
Total data acquisition (DAQ) time was 10 min on average.
Structured light patterns were generated using C# code and
an ALP applications program interface, MI Acquire (v1.3.12),
provided by Modulated Imaging Inc. (Irvine, California). A 12-
bit CCD-based camera, coregistered with the projector, captured
narrow bands of spectral reflectance using interference
filters. Illuminating at a small angle to normal incidence and
cross-linear polarizers placed at the source and detector mini-
mized specular reflections. Figure 1 shows the fully integrated
projection and camera subsystems mounted on a z-axis post.1,37
Fig. 1 Compact SFDI mounted on a z-axis post in light-shielded con-
tainer; imaging a calibration standard in reflectance geometry.
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2.2 Data Acquisition and Calibration
A planar and harmonically varying source illuminated each sam-
ple in reflectance geometry at normal incidence according to
q ¼ q0ðzÞ cosðkxxþ αÞ: (1)
Here, q0ðzÞ represents the decay of the source as a function
of depth in the media, α represents its phase offset, and
fx ¼ kx∕2π describes the spatial frequency of modulation in
the x-direction. Assuming a linear medium and symmetry
considerations, each sinusoidal source gave rise to a reflected
intensity (IAC) with the same frequency and phase:
1
IACðx; y; fx; αÞ ¼ MACðx; y; fxÞ cosðkxxþ αÞ: (2)
A three-phase demodulation was then employed to extract
the frequency dependent modulation amplitude, MAC, from
the reflected intensity and to remove ambient noise common






 ½IACðfx; α1Þ − IACðfx; α2Þ2 þ ½IACðfx; α2Þ − IACðfx; α3Þ2




The modulation amplitude of a siloxane titanium dioxide
(TiO2) reflectance standard with expected optical properties,
MAC;ref , was measured at each imaging session for phantom-
based calibration and to correct for spatial nonuniformity in
the illumination and imaging systems. The reference standard
was characterized by diffuse optical spectroscopy (DOS),
which combines frequency domain photon migration with
broadband spectroscopy.39 Diffuse reflectance of the standard
(Rd;ref) was predicted from its expected optical properties
using a forward model of light transport. Absolute reflectance





Each spatial sampling point was calibrated and analyzed
separately.
2.3 Comparison of Analytical Models of Reflectance
Optical parameters were fit by minimizing the residual sum of
squares between the measured modulation amplitude and its
analytical solution in a semi-infinite, turbid medium, modeled
according to diffusion16 and scaled-Monte Carlo simulations
of light transport.25 The former approximation assumes isotropic
scattering and the latter, a Henyey-Greenstein phase function.1
Rescaling a single, spatially and temporally resolved Monte
Carlo simulation significantly reduced the computational burden
associated with iterative estimation of optical parameters.
However, computing its Fourier transformation was still time
intensive in a minimization scheme. Consequently, scaled-
Monte Carlo simulations of the modulation amplitude were
stored in a 30-frequency, 4-wavelength, look up table (LUT)
to reduce the computational burden associated with iterative
estimation of spectral parameters. The LUT modulation ampli-
tude was computed for absorption coefficients varying from 0 to
0.0999 mm−1 in steps of 1.9057E-04 mm−1 and scattering coef-
ficients varying from 0.2495 to 2.1495 mm−1 in steps of
0.0019 mm−1. A LUT was not implemented for the diffusion
approximation because computation of its forward analytical
solution was direct; however, other groups have implemented
this to improve speed of optical parameter rendering.1 Cuccia
et al. compared the accuracy of the diffusion approximation
and scaled-Monte Carlo simulation of light transport using com-
puter simulations for a range of optical pathlengths, and showed
that for low spatial frequencies in a medium with an albedo
approaching 1, the diffusion error remains less than 16%.1
Here, model-data goodness of fit was evaluated in modulated
reflectance measurements acquired from 47 patients in a
HIPAA-compliant, prospective study, approved by Institutional
Review Board for the protection of human subjects common to
evaluate the applicability of these models to light scattering in
surgical breast tissues. The adjusted R2 coefficient of determi-
nation was used to quantify data variance explained by the
model and the lowest adjusted Akaike information criterion
(AIC) was used to rank model performance because it is
based on the negative log likelihood of the residuals and con-
sequently, provided a relative assessment of nonlinear model fit
(the R2 coefficient of determination is known to inadequately
assess nonlinear regression because the total sum of squares
is not equal to the regression sum of squares, as in the linear
case).40,41 A spectrally constrained optimization was explored
with the diffusion approximation given a priori knowledge of
the chromophore extinction spectra and the wavelength-depend-
ence of the reduced scattering coefficient. However, an uncon-
strained optimization was observed to be more robust given the
limited number of wavelengths sampled. The ability of recov-
ered spectral parameters to distinguish breast tissue types in this
large tissue population are evaluated elsewhere; here the optimi-
zation of model-data fit is presented.
2.4 Optical Parameter Recovery
Spectral parameters were subsequently fit according to absorp-
tion by the endogenous tissue chromophores, oxygenated-
hemoglobin (HbO2), deoxygenated-hemoglobin (Hb), and water,
and the wavelength-dependence of light scattering. Concen-
trations of HbO2 and Hb were recast as total hemoglobin
(HbT ¼ HbO2 þ Hb) and percent oxygen (%O2 ¼ HbO2∕HbT).
A power law dependence on wavelength was used to describe
the Mie scattering spectrum: the scattering amplitude (A) and
scattering power (b) were calculated relative to the reduced scat-
tering coefficient of 1% intralipid at λ0 ¼ 800 nm42







Adipose was not included in the basis set of fit chromophore
extinction spectra because the four wavelengths sampled were
insufficient to uniquely separate water and lipid absorption; an
assumption about lipid absorption was necessary during
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optimization to prevent saturation of percent lipid or percent
water at its bounds, as previously discussed by Mazhar.43
Suspected lesions were primarily fibroglandular and pathol-
ogy-assessed lesions were on average, 3% adipose, as deter-
mined prospectively by immunohistochemistry.
2.5 Tissue Simulating Phantoms
A homogeneous, polymer-based phantom with inclusion wells
varying in diameter (1.25 to 15 mm) was custom designed and
constructed by INO Inc. (Biomimics phantom, Quebec City,
Quebec, California) for contrast-detail analysis. The absorption
and reduced scattering coefficients of the phantom at 800 nm
were 0.008 and 1.006 mm−1, respectively; the refractive index
was 1.52 and carbon black was used as an absorber. The inclu-
sions were filled with dilutions of Intralipid, as shown in Fig. 2,
to determine the minimum size of detectable scattering contrast in
reduced scattering maps. Actual scattering contrast varied from
1% to 66% and was compared to measured scattering contrast;
plotted along the center x-axis of each phantom according to:
Contrast ¼ SA − SB
SA þ SB
; (6)
where SA is the signal from the inclusion and SB is the signal
from the background. Sensitivity to scattering contrast at depth
was additionally investigated using a gelatin phantom with scat-
tering heterogeneities embedded 0 to 3 mm in a homogenous
background, constructed with Intralipid and Nigrosin dye. Gelatin
was boiled, cooled to 40°C (warm to the touch, but not solidified),
and diluted with 10% Intralipid to the expected reduced scatter-
ing coefficient.44 Inclusions were carved in the gelatin once it
had cooled and were filled with another batch of liquid gelatin
with greater or lower Intralipid concentration, as described by
Pogue and Patterson.45
A series of homogenous liquid phantoms with expected
optical properties were imaged to test the absolute quantifica-
tion of absorption and reduced scattering coefficients by SFDI.
Phantoms were constructed from Intralipid-20% (Fresenius
Kabi, Uppsala, Sweden), a fat emulsion used to mimic scattering
in biological tissues, diluted with phosphate buffered solution
(PBS) and porcine blood.42 PBS was used to dilute the blood
to maintain blood cells at their physiological pH of 7.4.
Scattering concentrations varied from 0.5% to 2.0% and the
reduced scattering coefficient of each dilution was computed
per wavelength according to Michels et al.42 Initial dilutions
of porcine blood were prepared using measured hematocrit
values assayed with a HemoCue© meter (Hb 201 system,
HemoCue Inc., Cypress, California) for each sample, and the
final solution values were serially diluted from 60 to 3.75 μM,
the expected physiological range in breast tissue.46 Expected
optical properties were subsequently calculated using the for-
ward model of light transport and assuming the chromophore
extinction spectra.44 The Pearson’s correlation coefficient, and
coefficient of variation for all expected and recovered optical
parameters were computed for model comparison. The coeffi-
cient of variation is just the standard deviation normalized to
Fig. 2 Contrast-detail curves for scattering heterogeneities that vary in size (x-axis) and contrast (y-axis); measured at (a) 658 nm, (b) 730 nm, (c) 850 nm,
and (d) 970 nm.
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the distribution mean, and approaches 1 when two variables
change together exponentially.
2.6 Spatial Frequency Domain Imaging of
Lumpectomies
Four fully intact and un-inked lumpectomy specimens were
imaged immediately upon excision at the time of primary sur-
gery to test the clinical translation of this new technology. The
surgeon participated in each imaging session and placed sutures
in the excised tissues to safeguard knowledge of its orientation
until surgical inks were applied and the tissue was sent to path-
ology. Fifteen spatial frequencies uniformly distributed between
0 and 0.33 mm−1 were projected per wavelength onto each
margin in under 2 min and spectral parameters were recon-
structed using the scaled-Monte Carlo LUT. Tissues were




Maps of the reduced scattering coefficient are shown in Fig. 2
for the contrast-detail phantoms and contrast line scans are
plotted in Fig. 3(a) through 3(d). Detectable scattering con-
trast decayed asymptotically with inclusion size, as shown in
Fig. 4(a): a 1.25 mm diameter inclusion was detectable when
scattering contrast was at least 28%; the lowest detectable
scattering contrast was 7% when the inclusion diameter was
at least 10 mm. Recovered scattering contrast was observed
to be lower than the expected scattering contrast, indicated
by the dashed lines in Fig. 3(a) through 3(d), likely due to
assumptions made about the optical properties of the inclusions.
Figure 4(a) shows that absorption contrast, due to variations in
phantom water content, was not detectable for inclusions less
than 5 mm in diameter and absorption maps were characterized
by a low signal-to-noise ratio (SNR). Figure 5(a) shows the
reduced scattering coefficient maps for three phantoms with
scattering inclusions placed at depths of 0 to 3 mm. True scat-
tering contrast is mapped in Fig. 5(b); at least 33% scattering
contrast was detectable at a 1.5 mm depth. The minimum detect-
able scattering contrast as a function of inclusion depth is plotted
in Fig. 4(b) for the gelatin phantom; similar levels of detectable
scattering contrast were observed in the polymer-based phan-
tom. No absorption contrast was introduced into the gelatin
phantom and absorption maps showed low signal to noise
ratio (SNR) and minimal cross talk with scattering signatures,
particularly with increasing inclusion depth.
3.2 Absolute Quantification of Optical Parameters
Recovered and expected optical parameters for Intralipid
phantoms, serially diluted with porcine blood and extracted
from the scaled-Monte Carlo LUT, are plotted in Fig. 6(a)
and 6(d). The reduced scattering coefficient was systematically
underestimated (on average, by 26%), but relative trends in the
spectral scattering amplitude and slope were conserved. Syste-
matic error in the absolute quantification of scattering was likely
influence by the assumed optical parameters of the calibra-
tion phantoms, which for Intralipid, was derived by Michels42
using Mie theory and a different acquisition geometry. Spectral
Fig. 3 (a)–(d) Detected contrast in reduced scattering maps for each contrast detail phantom per wavelength (indicated by color); scattering contrast is
plotted along the center x-axis of each phantom. Expected scattering contrast per wavelength indicated by dashed line.
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Fig. 4 (a) Minimum detectable scattering contrast plotted as a function of inclusion diameter for the reduced scattering coefficient and absorption
coefficient. (b) Minimum detectable scattering contrast plotted as a function of inclusion depth for the reduced scattering coefficient. Absorption
contrast was not detectable for inclusion diameters less than 5 mm in these phantoms.
Fig. 5 (a) Reduced scattering maps (mm−1) as a function of wavelength and depth for a gelatin phantom with true scattering contrast illustrated in (b)
and homogenous absorption (0.005 mm−1).
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parameters extracted from the NIR optical coefficients are plot-
ted as a function of Intralipid and hemoglobin concentration in
Fig. 6(b) and 6(c) as well as in 6(e) and 6(f). Recovered hemo-
globin values demonstrated insensitivity to scattering variations
except at low concentrations and were withinþ∕ − 12% of their
expected values. The absorption coefficient was overestimated
at visible wavelengths for low hemoglobin concentrations
(<15 uM) because of the shorter pathlengths sampled. Water
quantification was independent of hemoglobin changes and
oxygenation levels approached 100% for all liquid phantoms
(data not shown). Systematic under-estimation of absorption
parameters at 970 nm was observed, likely due to the assump-
tions about the expected water absorption in the phantoms.
Errors in Fourier Sampling theory may have also contributed
minimally to amplitude underestimation, and consequently
absorption overestimation, at low spatial frequencies.1 The scat-
tering coefficient demonstrated insensitivity to hemoglobin
variations, except at the measured concentration limits (0 and
60 μM). The scattering amplitude increased linearly with scat-
tering concentration (low coefficient of variation with Intralipid
concentration: 0.26), but the scattering slope depended on both
the particle size and number density (high coefficient of varia-
tion with Intralipid concentration: 1.36). All recovered absorp-
tion and scattering parameters showed strong correlation with
their expected values (>0.97).
3.3 Forward Model Selection
Table 1 compares the diffusion approximation and scaled-Monte
Carlo simulations of light transport according to model-data
goodness of fit in a large cohort of surgical breast tissues.
Three variations of the diffusion approximation were explored:
a spectrally unconstrained model (a) and two spectrally con-
strained models (b) and (c), whose optimized parameters are
listed in Table 4.2, to investigate the dependence of GOF on
spectral constraints. The reduced scattering and absorption coef-
ficients were constrained, respectively, to a power law depend-
ence on wavelength and exponential extinction according to
tabulated chromophores. Model (c) implements the most severe
spectral constraints by linking the total concentration of hemo-
globin to oxygen saturation (bounded between 0% and 100%)
during optimization. GOF decreased with increasing spectral
constraints, likely due to sparse spectral sampling. The R2 coef-
ficient of determination shows that the spectrally unconstrained
diffusion model and scaled-Monte Carlo model performed com-
parably with regards to model-data goodness of fit, however the
lowest adjusted-AIC suggests that the scaled-Monte Carlo
model best minimized information loss in this population of
surgical tissues. The correlation between the recovered and
expected absorption and reduced scattering coefficients was
greater than 0.97 for all models; however their coefficient of
variation (CV) indicated some exponential trends in absorption
Fig. 6 (a) and (d) True (blue) and recovered (red) absorption and reduced scattering coefficients extracted from homogeneous, tissue simulating phan-
toms using scaled-MC simulations as a forward model. Intralipid concentrations varied from 0.5% 1.0% and 2.0%. Hemoglobin concentrations varied
from 0 to 60 uM in six serial dilutions. Parameters recovered at all four wavelengths are shown in sequence. (b) and –(c) Spectral absorption parameters
mapped as a function of hemoglobin concentration at three scattering concentrations (indicated by line color). (e) and (f) Spectral scattering parameters
mapped as a function of Intralipid concentration for six hemoglobin concentrations (indicated by line color). Error bars indicate the standard deviation
observed per 40 × 40 pixel window.
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estimates with absorber concentration for both the diffusion
(CV ¼ 0.86) and scaled-Monte Carlo models (CV ¼ 0.71);
likely because the high spatial frequencies probed are less sen-
sitive to the longer photon pathlengths associated with absorp-
tion. Sparse spectral sampling may have also limited the
accuracy of chromophore quantification. Recovered scattering
coefficients varied linearly with their expected values for both
models (CV ¼ 0.27 to 0.28). The scaled-Monte Carlo model
was selected because its recovered absorption parameters varied
more linearly with hemoglobin concentration in liquid phan-
toms within a physiologic hemoglobin range.
3.4 Challenges Associated with the Clinical
Translation of SFDI
Spectroscopic images of four surgical margins are shown in
Fig. 7: column A shows two wire-localized fibroadenomas
(0.7 to 0.8 mm in diameter) in a fibrocystic background and
column B shows four small fibroadenomas (0.2 to 0.5 cm in
diameter) in an otherwise complete pathologic response to neo-
adjuvent chemotherapy. Column C shows a nearly complete
pathologic response to chemotherapy, except one remaining
high-grade tumor focus (0.2 cm) in the fibrocystic background.
The lymphadenectomy associated with this partial responder is
shown in column D; 11 out of 15 lymph nodes were positive for
cancer. Oxygenation was the most apparent gauge of tumor
response to therapy in these four lumpectomy specimens; oxy-
gen levels in the lymph nodes filled with tumor were ∼40%
lower than those observed in pathologically responsive tumors
and fibroadenomas. Variation in optical parameters with time
delay after excision reported by Bydlon suggest that oxygen sat-
uration levels of hemoglobin vary nonlinearly within 30 min of
resection; whereas, the reduced scattering coefficient and total
hemoglobin concentration showed little change over time.47
Consequently, oxygenation could be a valuable diagnostic
parameter if imaged in the surgical cavity or immediately at
the time of resection. High spectroscopic scattering was ob-
served from fibrocystic tissues (columns A and C) and a
lower scattering slope distinguished two large fibroadenomas
within a fibrocystic background, as shown in column A.
Water content was elevated and oxygenation levels were lower
in the upper left quadrant of the partial responder (column C),
suggesting that this quadrant was the site of the high-grade
tumor focus. The primary challenges observed with the clinical
translation of SFDI were edge artifacts, which presented as
elevated absorption at the tissue edge, a typical location of
tissue profile decline, and orienting spectroscopic images
with pathology to validate margin status.
4 Discussion
In this paper, we investigate the ability of SFDI to discriminate
superficial scattering contrast in tissue simulating phantoms
and in surgical breast tissues. Higher spatial frequencies
were probed to increase sensitivity to scattering by tissue
ultra-structure because recent results suggest this is most reli-
able for tissue type discrimination,47 and scattering was
observed to display a more localized phenotype, as compared
to absorption phenomena. Evaluation of scattering contrast in
tissue-simulating phantoms showed that an inclusion as small
as 1.25 mm in diameter was detectable for scattering contrast at
least 28% and up to 7% scattering contrast was detected for a
10 mm inclusion; additionally, up to 33% scattering contrast
was detectable at depths of 1.5 mm. This spatial resolution
is sufficient to detect invasive cancers too large for effective
eradication by radiation therapy. Accuracy of the diffusion
approximation is known to be limited at high spatial fre-
quencies by the restriction of no radiant anisotropy within
the optical medium; here, the higher order approximation
to the scattering phase function employed by Monte Carlo
improved absorption quantification accuracy in breast tissues
for near-source recovery of nondiffusive optical parameters.48
Functional absorption parameters could complement informa-
tion provided by spectroscopic scattering, but the accuracy of
their quantification may be improved by increasing the density
of spectral sampling in the NIR and by acquiring more data at
low spatial frequencies.
Here, system analysis of SFDI highlights the depth selectiv-
ity of this planar acquisition geometry and explores the limita-
tions of its contrast-detail resolution, model-data goodness of
fit evaluated in surgical breast tissues, and the accuracy of opti-
cal parameter quantification. In the spatial frequency domain,
effective attenuation, and consequently probing depth, δeff ,
is a product of both the effective attenuation coefficient,
μeff ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
3μaðμa þ μ 0sÞ, and the illumination modulation fre-
quency, fx, such that μ 0eff ¼ ½μ2eff þ ð2πfxÞ21∕2 ¼ 1δeff . Con-
sequently, light is attenuated more rapidly at high spatial
frequencies yielding superficial interrogation of the speci-
men. At high spatial frequencies, the transport coefficient,
μtr ¼ μa þ μ 0s, is the primary source of optical contrast. In
the diffusion limit, this is predominantly a scattering signature.
Sampling with a modulation frequency up to 0.33 mm−1, we
demonstrated an ability to detect up to 33% scattering contrast
at the maximum depth relevant to surgical margin assessment
(1.5 mm). The analytical solution to the diffusion approximation
in the spatial frequency domain1 reveals that reflectance behaves
as an inverse function of the ratio, μeff∕μtr. Consequently, at low
Table 1 Goodness of fit evaluated in breast tissue for three variations of the diffusion
approximation and a scaled-Monte Carlo forward model, according to their average adjusted
R2 coefficient and the adjusted Akaike information criterion (AIC).





Diffusion (a) μa, μs 0 0.99 −656
Diffusion (b) A, b, [HbO2], [Hb], %H2O 0.98 −616
Diffusion (c) A, b, [HbT], %O2, %H2O 0.63 −343
Scaled Monte Carlo (LUT) μa, μs 0 0.99 −669
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spatial frequencies, absorption dominates optical contrast and
there is a relatively deeper interrogation depth. The camera
resolution and the number of sources (or spatial frequencies
projected per sample) additionally influence detectable contrast.
Finally, absolute quantification of optical parameters requires
a repeatable, stable calibration phantom with known optical
properties and all measures must be made at a uniform height
because the reflectance amplitude decays according to an
inverse square law. A three-phase amplitude de-modulation
scheme has been developed to correct for surface profile
changes,49 but continued efforts are needed to standardize
calibration phantoms across institutions.
Fig. 7 Photograph and spectral parameter maps sampled from four lumpectomy margins: (a) fibroadenomas (n ¼ 2) with diameters of 0.7 to 0.8 mm
surrounded by fibrocystic disease, (b) complete pathologic response to neoadjuvent chemotherapy and two small fibroadenomas (diameters of 0.2 to
0.5 mm); (c) partial response to neoadjuvent chemotherapy with residual high grade tumor focus (0.2 mm) and fibrocystic disease; (d) lymphadenec-
tomy associated with case (c). Cancer is present in 11/15 nodes. Skin andmuscle in the image field appear white and deep red, respectively in the tissue
photograph.
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An ability to detect small foci of DCIS would be significant
clinically because DCIS is typically nonpalpable and its pres-
ence critically impacts the planning of gross resection margins,
a significant factor affecting long-term patient care.50 DCIS is
typified by high-grade epithelial proliferation in the lumen
(which may or may not be associated with necrosis and
micro-calcifications) and fibrosis in the periductal stroma.51 It
is clinically treated as a preinvasive lesion, even though it is
not clear that all DCIS lesions progress to the invasive type.
Contrast-detail assessment in tissue-simulating phantoms sug-
gests that superficial clusters of DCIS, and not epithelial hyper-
proliferation within a single lumen, are detectable by SFDI.52,53
However, the increased depths probed by SFDI evaluate wider
margins appropriate for DCIS.
Conceivably, SFDI could readily improve resection com-
pleteness during breast conserving surgery by providing subsur-
face optical assessment of pathology in resected tissues.
Implementation of the scaled-Monte Carlo LUT significantly
reduced the computational burden associated with iterative esti-
mation of optical parameters to render data analysis feasible in
the operative setting. Data acquisition could be improved by
accounting for surface profile changes during optical parameter
recovery, increasing spectral resolution in the visible-NIR, and
developing inking strategies that improve coregistration of spec-
tral images with paraffin histology. Coregistration would be
more feasible if the surgeon applied inks subsequent to imaging,
but prior to removal of the tissue from the imaging platform.
That way, inks corresponding to each image field could be
recorded for pathology correlation. Precise coregistration with
pathology is only necessary to validate the technology—in
the surgical setting, near real-time imaging feedback would en-
able the surgeon to rotate the specimen and resect additional
tissues as necessary. Some research groups have developed
compact enclosures to maintain specimen orientation while
locally sampling tissue optical properties.54 Development of a
similar device would require considerable scalability given
the variation observed in resected tissue size/shape and
would likely induce imaging artifacts for this illumination
scheme. Edge artifacts were significantly observed in lumpec-
tomy specimens prior to gross sectioning, but a three-phase
amplitude de-modulation scheme has been developed to correct
for surface profile changes49 and will be implemented in future
studies. Translation of SFDI to surgical margin assessment
should focus on improving image reconstruction speed, auto-
mating combined acquisition of tissue and phantom calibration
data, and developing inking strategies for improved coregistra-
tion with pathology.
5 Conclusions
The ultimate goal of conservative surgery is to remove enough
primary cancer for effective eradication of microscopic residual
disease by radiation therapy. Here, tissue-simulating phantoms
with known properties were imaged for optimization of analysis
methods to determine the microscopic sensitivity of SFDI. A
1.25 mm diameter inclusion was detectable when scattering con-
trast was at least 28%; a quarter of this scattering contrast (7%)
was detectable for 10 mm inclusions and at least 33% scattering
contrast was detected up to 1.5 mm in depth. Relative trends in
the spectral scattering amplitude and slope were conserved and
recovered scattering parameters demonstrated insensitivity to
hemoglobin changes. Recovered hemoglobin concentrations
demonstrated insensitivity to changes in scattering, except at
low hemoglobin concentrations (<15 μM), where they were
overestimated at visible wavelengths, but within 12% of their
true range. The scattering amplitude increased linearly with scat-
tering concentration, but the scattering slope depended on both
the particle size and number density. Absorption parameters
extracted using scaled-Monte Carlo simulations of light trans-
port varied most linearly with expected hemoglobin concentra-
tion in liquid phantoms and minimized information loss when
fitting reflectance spectra acquired from surgical breast tissues at
higher spatial frequencies. Data acquisition was ultimately
tested in four fully intact, lumpectomy tissues and a workflow
was established for acquisition and analysis to facilitate the
clinical translation of this technology to breast conserving sur-
gery. The primary challenges observed with the clinical trans-
lation of SFDI were: edge artifacts induced by tissue surface
profile changes and orienting spectroscopic images with path-
ology to validate margin status; these may be overcome by sur-
face profile correction algorithms and inking strategies
coordinated with the surgeon. SFDI has the potential to effec-
tively detect tissue subtypes in surgical breast lesions because it
maintains sensitivity to local scattering contrast over a wide field
and data is acquired in a noncontact geometry.
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